These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 19118012)
21. COOH-terminal Src kinase-mediated c-Jun phosphorylation promotes c-Jun degradation and inhibits cell transformation. Zhu F; Choi BY; Ma WY; Zhao Z; Zhang Y; Cho YY; Choi HS; Imamoto A; Bode AM; Dong Z Cancer Res; 2006 Jun; 66(11):5729-36. PubMed ID: 16740711 [TBL] [Abstract][Full Text] [Related]
22. Ribosomal S6 kinase 2 is a key regulator in tumor promoter induced cell transformation. Cho YY; Yao K; Kim HG; Kang BS; Zheng D; Bode AM; Dong Z Cancer Res; 2007 Sep; 67(17):8104-12. PubMed ID: 17804722 [TBL] [Abstract][Full Text] [Related]
23. Epimagnolin targeting on an active pocket of mammalian target of rapamycin suppressed cell transformation and colony growth of lung cancer cells. Yoo SM; Lee CJ; Kang HC; Lee HS; Lee JY; Kim KD; Kim DJ; An HJ; Cho YY Mol Carcinog; 2019 Jul; 58(7):1221-1233. PubMed ID: 30887599 [TBL] [Abstract][Full Text] [Related]
24. c-jun and multistage carcinogenesis: association of overexpression of introduced c-jun with progression toward a neoplastic endpoint in mouse JB6 cells sensitive to tumor promoter-induced transformation. Watts RG; Ben-Ari ET; Bernstein LR; Birrer MJ; Winterstein D; Wendel E; Colburn NH Mol Carcinog; 1995 May; 13(1):27-36. PubMed ID: 7766308 [TBL] [Abstract][Full Text] [Related]
25. Identification of a co-activator that links growth factor signalling to c-Jun/AP-1 activation. Davies CC; Chakraborty A; Cipriani F; Haigh K; Haigh JJ; Behrens A Nat Cell Biol; 2010 Oct; 12(10):963-72. PubMed ID: 20852630 [TBL] [Abstract][Full Text] [Related]
26. Epidermal growth factor and c-Jun act via a common DNA regulatory element to stimulate transcription of the ovine P-450 cholesterol side chain cleavage (CYP11A1) promoter. Pestell RG; Albanese C; Watanabe G; Johnson J; Eklund N; Lastowiecki P; Jameson JL J Biol Chem; 1995 Aug; 270(31):18301-8. PubMed ID: 7629150 [TBL] [Abstract][Full Text] [Related]
27. Requirement for phosphatidylinositol 3-kinase in epidermal growth factor-induced AP-1 transactivation and transformation in JB6 P+ cells. Huang C; Ma WY; Dong Z Mol Cell Biol; 1996 Nov; 16(11):6427-35. PubMed ID: 8887671 [TBL] [Abstract][Full Text] [Related]
28. 5'-Nitro-indirubinoxime inhibits epidermal growth factor- and phorbol ester-induced AP-1 activity and cell transformation through inhibition of phosphorylation of Pin1. Khanal P; Choi HK; Namgoong GM; Ahn SG; Yoon JH; Sohn H; Choi HS Mol Carcinog; 2011 Dec; 50(12):961-71. PubMed ID: 21400615 [TBL] [Abstract][Full Text] [Related]
29. The cancer/testis antigen CAGE with oncogenic potential stimulates cell proliferation by up-regulating cyclins D1 and E in an AP-1- and E2F-dependent manner. Por E; Byun HJ; Lee EJ; Lim JH; Jung SY; Park I; Kim YM; Jeoung DI; Lee H J Biol Chem; 2010 May; 285(19):14475-85. PubMed ID: 20220142 [TBL] [Abstract][Full Text] [Related]
30. A potential role of connexin 43 in epidermal growth factor-induced proliferation of mouse embryonic stem cells: involvement of Ca2+/PKC, p44/42 and p38 MAPKs pathways. Park JH; Lee MY; Heo JS; Han HJ Cell Prolif; 2008 Oct; 41(5):786-802. PubMed ID: 18823499 [TBL] [Abstract][Full Text] [Related]
31. The mitogen-activated protein kinase p38 regulates activator protein 1 by direct phosphorylation of c-Jun. Humar M; Loop T; Schmidt R; Hoetzel A; Roesslein M; Andriopoulos N; Pahl HL; Geiger KK; Pannen BH Int J Biochem Cell Biol; 2007; 39(12):2278-88. PubMed ID: 17689131 [TBL] [Abstract][Full Text] [Related]
32. 2-Arachidonoylglycerol stimulates activator protein-1-dependent transcriptional activity and enhances epidermal growth factor-induced cell transformation in JB6 P+ cells. Zhao Q; He Z; Chen N; Cho YY; Zhu F; Lu C; Ma WY; Bode AM; Dong Z J Biol Chem; 2005 Jul; 280(29):26735-42. PubMed ID: 15886210 [TBL] [Abstract][Full Text] [Related]
33. Cdk3-promoted epithelial-mesenchymal transition through activating AP-1 is involved in colorectal cancer metastasis. Lu J; Zhang ZL; Huang D; Tang N; Li Y; Peng Z; Lu C; Dong Z; Tang F Oncotarget; 2016 Feb; 7(6):7012-28. PubMed ID: 26755651 [TBL] [Abstract][Full Text] [Related]
35. The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1. Frank RC; Sun X; Berguido FJ; Jakubowiak A; Nimer SD Oncogene; 1999 Mar; 18(9):1701-10. PubMed ID: 10208431 [TBL] [Abstract][Full Text] [Related]
36. Differential c-jun expression in response to tumor promoters in JB6 cells sensitive or resistant to neoplastic transformation. Ben-Ari ET; Bernstein LR; Colburn NH Mol Carcinog; 1992; 5(1):62-74. PubMed ID: 1543542 [TBL] [Abstract][Full Text] [Related]
37. Divergence in signal transduction pathways of platelet-derived growth factor (PDGF) and epidermal growth factor (EGF) receptors. Involvement of sphingosine 1-phosphate in PDGF but not EGF signaling. Rani CS; Wang F; Fuior E; Berger A; Wu J; Sturgill TW; Beitner-Johnson D; LeRoith D; Varticovski L; Spiegel S J Biol Chem; 1997 Apr; 272(16):10777-83. PubMed ID: 9099730 [TBL] [Abstract][Full Text] [Related]
38. Role of mitogen-activated protein kinases and c-Jun/AP-1 trans-activating activity in the regulation of protease mRNAs and the malignant phenotype in NIH 3T3 fibroblasts. Janulis M; Silberman S; Ambegaokar A; Gutkind JS; Schultz RM J Biol Chem; 1999 Jan; 274(2):801-13. PubMed ID: 9873019 [TBL] [Abstract][Full Text] [Related]
39. Protein kinase D is sufficient to suppress EGF-induced c-Jun Ser 63 phosphorylation. Hurd C; Rozengurt E Biochem Biophys Res Commun; 2001 Mar; 282(2):404-8. PubMed ID: 11401472 [TBL] [Abstract][Full Text] [Related]
40. Gene regulation and genetic susceptibility to neoplastic transformation: AP-1 and p80 expression in JB6 cells. Bernstein LR; Ben-Ari ET; Simek SL; Colburn NH Environ Health Perspect; 1991 Jun; 93():111-9. PubMed ID: 1773784 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]